Skip to main content

111 Capital

Position in NBIX — Neurocrine Biosciences Inc

CIK 2060412 PARIS, I0

Position in NBIX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$442,923
+$198,943 QoQ
Shares Held
2,628
+51.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#491
of 768 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

111 Capital holds $1,160,270 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (38.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
2,628 $442,923

All Filings in NBIX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $442,923 2,628
2025-09-30 $243,980 1,738